Oral lipomatosis in antiretroviral therapy-associated lipodystrophy syndrome.
Shetty
Kishore
K
Medically Complex Patient Clinic, The University of Texas, Health Science Center at Houston, Houston, TX 77030, USA. kishore.shetty@uth.tmc.edu
D044966:Anti-Retroviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D050218:Body Fat Distribution; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy; D006679:HIV Seropositivity; D039682:HIV-Associated Lipodystrophy Syndrome / Q000150:complications* / Q000601:surgery; D006801:Humans; D008068:Lipomatosis / Q000139:chemically induced* / Q000150:complications / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009060:Mouth Floor / Q000473:pathology / Q000601:surgery*; D050151:Subcutaneous Fat / Q000473:pathology / Q000601:surgery
D044966:Anti-Retroviral Agents